subchapter_subject: "ANIMAL DRUGS, FEEDS, AND RELATED PRODUCTS"
part_code: "520"
part_subject: "ORAL DOSAGE FORM NEW ANIMAL DRUGS"
subpart_code: "B"
subpart_subject: "Specific Administrative Rulings and Decisions"
section_number: "520.1084"
section_subject: "Grapiprant."
cfr_reference: "21 CFR 520.1084"
title_name: "Title 21"
title_subject: "Food and Drugs"
parts_covered: "Parts 500 to 599"
revised_date: "Revised as of April 1, 2019"
publication_date: "As of April 1, 2019"
contains_description: "Containing a codification of documents of general applicability and future effect"
publication_info: "Published by the Office of the Federal Register National Archives and Records Administration as a Special Edition of the Federal Register"
---
(a)Specifications. Each tablet contains 20, 60, or 100 milligrams (mg) grapiprant.
(b)Sponsor. See No. 058198 in § 510.600(c) of this chapter.
(c)Conditions of use in dogs—(1) Amount. Administer 0.9 mg/lb (2 mg/kg) once daily by mouth.
(2)Indications for use. For the control of pain and inflammation associated with osteoarthritis in dogs.
(3)Limitations. Federal law restricts this drug to use by or on the order of a licensed veterinarian.